Our flagship product is the XB Bio-Integration Suite, a complete, fully integrated biological and medical informatics solution for translational research, designed to accelerate the discovery and implementation of molecular-based preventative, diagnostic, and therapeutic approaches to medicine. It represents a unique systems approach for a range of purposes including basic biomedical research, clinical diagnostics, and identifying new pharmacogenomic strategies. Ultimately, the XB Bio-Integration Suite facilitates the efforts of academic and commercial researchers as well as clinicians to turn research-based ideas into valuable clinical practice.
The XB Bio-Integration Suite uses multiple model systems to identify and validate biomarkers and therapeutic targets of disease on a single, cohesive platform. This information ranges from results from cell-based assays to preclinical animal models and clinical subjects. Our platform yields significant intellectual property-rich data that may eventually allow for the definitive diagnosis and treatment of any disease with an underlying molecular basis. Our vision is that the XB Bio-Integration Suite will automatically determine the most plausible diagnostic and therapeutic strategies for a wide variety of conditions based upon statistical assessment of the database content.
For more information,